When it comes to Bio Tech ETFs, performance over the past year has varied greatly. The chart below looks at iShares Nasdaq Biotechnology (NASDAQ:IBB) and SPDR S&P Biotech (NYSE:XBI), both Biotech ETF’s. As you can see, XBI is doing much better in 2015 than IBB, up almost 100% more.
Below looks at the patterns in IBB and XBI, which do have different patterns to say the least!
The chart of IBB on the left reflects a 4-year rising support line was broken and kissed as resistance at the red arrow above.
XBI on the other had, remains well inside of a 4-year rising channel.
These Biotech ETF’s are not built the same and the leading performer of the two remains inside of this rising channel. I will be concerned for this sector and the broad markets if XBI breaks below support.